JACIE accreditation asks for a complete quality management that is an assurance system (manual of standard operating procedures) and a teamwork's management documentation. At several steps of the chemotherapy intensification with stem cell autologous graft(s), the nurse is involved in the care evaluation. JACIE patient handover process starts at the first doctor consultation, going through the patient consent and adhesion to intensification and graft(s), education to the life in sterile unit, intensive care, one year post engraftment follow up. Objectives: to improve the documentation from a mosaic of processes and procedures to a description that shows nurse and physician commitment. Actors task's: 2 seniors nurses as quality referent and his locum were appointed. First role: As nurse, the quality referent is able to define and set risk procedures. Risk means that there is nothing behind the action that allows detecting high prejudicial errors (for patient and/or staff). Then staff responsibilities definition concerning the risk procedure structures and makes efficient the new staff training and allows the staff rotation in a secured system. Risk procedures in the pediatric autologous graft unit: stem cells infusion, high dose chemotherapy, antifungal, antibiotherapy, growth factor, antiviral, blood component administration, microbiological positive marker patient management (serologies, chickenpox…), laminar flux management. The quality referent was involved in the "detection and evaluation of errors, accidents, adverse reactions process". He became the "godfather" responsible of its management in order to ensure declarations and follow-up. Second role as quality referent is the documentation update. That doesn't consist of the entire writing. The procedures contents showed that the nurse remains also the pivotal contact for the patient during his care. With the engineer quality, Quality Assurance techniques were performed in order to improve the formalism from text to logograms. Commonly text procedures were too long and asked for a summary to be assimilated. Following the concept of process "owner", responsibilities were also clearly understood. The logogram formulation is now the image of the real team activity shared between senior physicians, juniors physicians, nurse managerial staff, manager quality, senior and junior nurses. This work was supported by a PHRC grant.
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N913 Sibling donors -legal and moral considerations?
A. Hewitt (London, UK)
The role of sibling donors within the area of Bone Marrow Transplantation remains a topical, emotive and somewhat controversial topic. Delaney (1996) defines that there is not a statute or care law that sanctions the donation of bone marrow by a child. Therefore, it is debatable whether a healthy sibling should be allowed to undergo a medical procedure for the benefit of another. However, an alternative legal approach would be to take the view that the parents can give valid consent to treatment, which is not 'against the best interests of the child'. Thus supporting the view that the effects of having treatment denied due to legal reasons would have a devastating impact on the family (Browett et al 1996) . Whilst there continues to be a certain amount of disagreement regarding the use of sibling donors, it is clear that it is essential for donors to be protected and prepared effectively. This highlights several issues, which include the need for effective Psycho -social support, informed consent and preparation and education of all members of the family regarding the forthcoming procedure. At Great Ormond Street we have a formal preparation structure, which involves all members of the multi-disciplinary team; as health care professionals, we have a moral responsibility to ensure that the child is adequately prepared and has appropriate understanding. This presentation will discuss the legal and moral issues within the area of sibling donation. This will lead to discussing a framework for future practice and implications this may have for future practice.
N914
Needs of caregivers of hematopoietic stem cell transplant patients in Turkey S. Kav, O. Aslan, C. Meral, F. Tekin, H. Yesil, U. Ozturk, Z. Bulut, A. Enaboifo, M. Dover, B. Yazar (Ankara, TR) Hematopoietic stem cell transplantation (HSCT) is a life threatening procedure with long-term effects on QOL. Caregivers have important role during and after HSCT process. This study has been carried for identifying the needs, psychological and social problems of HSCT patient's caregivers during and after the HSCT process. The sample of the study, which consists of 58 caregivers, was selected from the patients who were underwent transplantation and being followed-up in five BMT units in Ankara, Turkey. The person who took responsibility as a caregiver during and after transplantation, should have at least primary school education and capable of giving informed consent to be eligible. The data were collected via questionnaire, which includes demographic characteristics and "psychological and social problems inventory" developed by one of the nurse researcher in Turkey. The inventory consists of 52 items that identify seven psychological and six social problem variables. The questionnaires were mailed or given to caregiver during their clinic visit. Almost all caregivers were one of the close family members, except one was a friend; half of them were patient's spouses (51.8%). Most of them were married (79.3%), male (51.8%) and have average 2 children (range 1-5). Forty caregivers reported they have at least one other person who gives assistance (mean: 2.6, range 1-6 people). Most of caregivers (86.2%) stated that they have been informed about transplantation by physician and/or nurse before transplantation and 67.2% of t hem were satisfied with these information, remaining portion (32.8%) was mostly curious or unsatisfied with information on disease, outcome or homecare after treatment. Caregivers preferred mostly taking one-to-one instruction from health professional and meeting other caregivers as highly rated educational methods. Psychological and social problems inventory provided that, the most experienced psychological problems by caregivers of HSCT patient's are fear and anxiety. Impaired social interaction, leisure activity deficit, impaired care management and home maintenance managements are the most experienced social problems by the caregivers. The information gathered from this study will guide us for reconsidering our services for both patients and caregivers to achieve improvement to support psychological and social aspects of the disease as a whole.
N915
Ambulatory allogeneic peripheral blood stem cell transplantation: a single center experience C. Broc, I. Acko, F. Chappe, L. Caymaris, E. Benamo (Marseille, F) Allo-PBSCT is a curative treatment for different hematological malignancies. Although the use of PBSC in this setting resulted in easier graft collection and quicker engraftment, procedurerelated toxicities and the impact on the quality of life due to the necessity of hospitalization still represent important issues. Recently, reduced intensity or nonmyeloablative conditioning regimens (RIC) were developed with minimal procedure-related toxicity, extending the use of allo-PBSCT to elderly patients (>50) or patients with a poor performance status. With this background, we investigated the feasibility of RIC allo-PBSCT in an ambulatory setting. Inclusion criteria included: (i) patients aged between 18 and 65 candidates to allo-PBSCT; (ii) absence of medical comorbidities precluding ambulatory care; (iii) patient home located within a maximum distance of 30 Km from the hospital; (iv) availability of a permanent accompanying family member. Patients were discharged immediately after PBSC infusion. Following discharge, patients were either systematically seen at the day-hospital 3 times/w or followed at home by the ambulatory "home hospital" team and seen once/w at the dayhospital. If necessary, patients could enter in contact by phone 24h/24h with the medical or nursing team. For the purpose of this protocol, the nursing team received a specific training and realized a homogeneous educational plan focusing on infectious and hemorrhagic complications. The patients were also educated to detect clinical signs of anemia and to anticipate painful complications such as mucositis. We present here the first results of this ongoing protocol obtained from the first 14 voluntary patients. In comparison to conventional allo-PBSCT, no significant differences were found in terms of febrile episodes or number of days of antibiotherapy. Time to reach an ANC > 0.5 x10e9/L and the number of transfusions were comparable. Furthermore, 6 patients (43%) were never re-admitted with a follow-up of more than 3 months post allo-PBSCT. The remaining 8 patients who were re-admitted for febrile episodes or GVHD, could stay at home for a mean time of 15 days before readmission. These encouraging results confirm that RIC-based allo-PBSCT is feasible in an ambulatory setting without additional secondary effects for the patient. We are now performing a detailed analysis of quality of life and anxiety parameters that appear to be improved in patients receiving ambulatory allo-PBSCT.
N916
First results of a prospective randomized study comparing outpatient follow-up versus conventional hospitalization after high-dose chemotherapy and PBSC autologous transplantation for hematologic malignancies or solid tumors C. Faucher, A. Le Corroller, N. Vey, G. Damaj, A. Stoppa, J. Schiano, F. Viret, G. Gravis, C. Chabannon, D. Maraninchi, P. Viens, D. Blaise (Marseille, F) Reported "outpatient follow up" programs after PBSCT often replace hospital stay by daily follow-up in an "intensive care" outpatient Clinic, or home care program, and none has been randomized. We prospectively address this question for patients treated in our center with HDCT and Autologous PBSCT, and present the first randomized study comparing clinical, and socioeconomic consequences of a non-intensive outpatient follow up versus conventional hospitalization after PBSCT. Protocol design: Patients aged 18-65 years, with indication of HDCT and PBSCT (graft >3x10e6 CD34+/kg) are included after informed consent. 140 pts planned, randomly assigned to Arm A: outpatient follow-up (HDCT in classical hospitalization, discharge at D0= PBSCT, home stay with a family caregiver, outpatient clinic visits 3 times a week until ANC >1 G/l, readmission at any time if clinically needed) or Arm B (HDCT, PBSCT and follow up until ANC>1 G/l in fully classical hospitalization). Study period: D0 to D+60. Main end point of the study: to compare the 2 groups for the total number of days spent in hospital (n° of visits in outpatient clinic + n° of days in classical hospitalization) during the same two months period. Pts and the designated caregiver are given validated autoquestionnaires to describe their quality of life, anxiety, and satisfaction. Results: To date, 74 pts have been included (55 HM, 19 ST), of whom 65 have completed the study (31 pts arm A, 34 pts arm B) . No pt presented serious complication while at home, and at interim analysis no difference was found for total n° of days in hospital for groupA vs groupB between the 2 groups (11 d vs 13 d). However, only 16/31 pts were discharged as scheduled in group A (50%). Nine pts refused, and 6 pts stayed for medical reasons. Of note, the "really outpatient" subgroup of 16 pts spent only 9 days in hospital, and 5 pts among them were not readmitted at all. All patients completed the first autoquestionnaire and the overall compliance for the quality of life study is quite high (86%). Detailed clinical and socioeconomic data will be presented. If these results are confirmed by the final analysis, it appears that the next challenge of the autologous PBSCT patients management would be first, to identify patients who clinically can and psychologically want to leave the hospital, and secondly, to improve the management of the other patients to offer them the same choice.
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Principles and nursing practice in patients with skin acute graft-versus-host disease M. Hebras, M. Bordy, Y. Idir, K. Tabani, H. Espérou, G. Socié, E. Gluckman (Paris, F) Our team is actively involved in the European accreditation process (JACIE) ; this gave us the opportunity to discuss about our protocols and procedures especially in the definition of our clinical practice in order to improve patients'care. We decided to focus our interest in the care of patients during skin acute GvHD.Acute GvHD is a frequent and potentially lethal complication in allogeneic stem cell transplantation, it occurs in the first three months after transplant. Target organs are skin, gastro intestinal tract and liver. Four grades (1 to 4) have been described, depending of the extension and severity of the lesions. Treatment of cutaneous acute GvHD includes both immunosuppressive drugs and local care. However our nurse experience on these patients showed a multidimensional perspective. Our practice includes different actions : 1. The prevention of infection related to the use of immunosuppressive drugs and cutaneous damages: local care with antiseptics, oil ointment prevention of bed sores, sterile coverage of ulcerations ; the patients' care in a laminar airflow room ; the strict usage of sterile measures including handwash, sterile gowns and gloves ; sterile drugs preparation and infusion. 2. The evaluation and treatment of pain. This evaluation includes analogy evaluation pain intensity, relationship with the physicians staff for the daily treatment modification, detection of anxiety, depression or aggressiveness related to the pain, use of a special bed such as air mattress. 3. The integration of psychological impact related to the change of patient's corporeal image. 4. Physical therapy and mobilisation when possible. Moreover, care of these patients is also based on listening, respect and take into account patient's emotions and dignity. 5. Education of the patient and his or her family.
